These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 32448342)
1. Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study. Bucksch K; Zachariae S; Aretz S; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Kloor M; von Knebel Doeberitz M; Morak M; Möslein G; Nattermann J; Perne C; Rahner N; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vangala DB; Weitz J; Loeffler M; Engel C; BMC Cancer; 2020 May; 20(1):460. PubMed ID: 32448342 [TBL] [Abstract][Full Text] [Related]
2. Adenoma and colorectal cancer risks in Lynch syndrome, Lynch-like syndrome and familial colorectal cancer type X. Bucksch K; Zachariae S; Ahadova A; Aretz S; Büttner R; Görgens H; Holinski-Feder E; Hüneburg R; Kloor M; von Knebel Doeberitz M; Ladigan-Badura S; Moeslein G; Morak M; Nattermann J; Nguyen HP; Perne C; Redler S; Schmetz A; Steinke-Lange V; Surowy H; Vangala DB; Weitz J; Loeffler M; Engel C; Int J Cancer; 2022 Jan; 150(1):56-66. PubMed ID: 34469588 [TBL] [Abstract][Full Text] [Related]
3. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer. Carethers JM; Stoffel EM World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352 [TBL] [Abstract][Full Text] [Related]
4. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. Lindor NM; Rabe K; Petersen GM; Haile R; Casey G; Baron J; Gallinger S; Bapat B; Aronson M; Hopper J; Jass J; LeMarchand L; Grove J; Potter J; Newcomb P; Terdiman JP; Conrad P; Moslein G; Goldberg R; Ziogas A; Anton-Culver H; de Andrade M; Siegmund K; Thibodeau SN; Boardman LA; Seminara D JAMA; 2005 Apr; 293(16):1979-85. PubMed ID: 15855431 [TBL] [Abstract][Full Text] [Related]
5. Risk of cancer in individuals with Lynch-like syndrome and their families: a systematic review. Nugroho PP; Ghozali SAS; Buchanan DD; Pisano MI; Reece JC J Cancer Res Clin Oncol; 2023 Jan; 149(1):25-46. PubMed ID: 36251064 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics of Lynch-like syndrome. Nakamori S; Takao M; Takao A; Natsume S; Iijima T; Kojika E; Nakano D; Kawai K; Inokuchi T; Fujimoto A; Urushibara M; Horiguchi SI; Ishida H; Yamaguchi T Int J Clin Oncol; 2024 Jul; 29(7):944-952. PubMed ID: 38642190 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry. Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542 [TBL] [Abstract][Full Text] [Related]
8. Implication of DNA repair genes in Lynch-like syndrome. Xicola RM; Clark JR; Carroll T; Alvikas J; Marwaha P; Regan MR; Lopez-Giraldez F; Choi J; Emmadi R; Alagiozian-Angelova V; Kupfer SS; Ellis NA; Llor X Fam Cancer; 2019 Jul; 18(3):331-342. PubMed ID: 30989425 [TBL] [Abstract][Full Text] [Related]
9. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers. Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875 [TBL] [Abstract][Full Text] [Related]
10. Clinical and Pathological Characterization of Lynch-Like Syndrome. Picó MD; Castillejo A; Murcia Ó; Giner-Calabuig M; Alustiza M; Sánchez A; Moreira L; Pellise M; Castells A; Carrillo-Palau M; Ramon Y Cajal T; Gisbert-Beamud A; Llort G; Yagüe C; López-Fernández A; Alvarez-Urturi C; Cubiella J; Rivas L; Rodríguez-Alcalde D; Herraiz M; Garau C; Dolz C; Bujanda L; Cid L; Povés C; Garzon M; Salces I; Ponce M; Hernández-Villalba L; Alenda C; Balaguer F; Soto JL; Jover R Clin Gastroenterol Hepatol; 2020 Feb; 18(2):368-374.e1. PubMed ID: 31220642 [TBL] [Abstract][Full Text] [Related]
11. Epidemiological, clinical and molecular characterization of Lynch-like syndrome: A population-based study. Porkka N; Lahtinen L; Ahtiainen M; Böhm JP; Kuopio T; Eldfors S; Mecklin JP; Seppälä TT; Peltomäki P Int J Cancer; 2019 Jul; 145(1):87-98. PubMed ID: 30575961 [TBL] [Abstract][Full Text] [Related]
12. Familial Colorectal Cancer Type X in Central Iran: A New Clinicopathologic Description. Zeinalian M; Hadian M; Hashemzadeh-Chaleshtori M; Salehi R; Emami MH Int J Hematol Oncol Stem Cell Res; 2017 Jul; 11(3):240-245. PubMed ID: 28989591 [No Abstract] [Full Text] [Related]
13. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas. Ju JY; Mills AM; Mahadevan MS; Fan J; Culp SH; Thomas MH; Cathro HP Am J Surg Pathol; 2018 Nov; 42(11):1549-1555. PubMed ID: 30148743 [TBL] [Abstract][Full Text] [Related]
14. PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors. Sloan EA; Ring KL; Willis BC; Modesitt SC; Mills AM Am J Surg Pathol; 2017 Mar; 41(3):326-333. PubMed ID: 27984238 [TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842 [TBL] [Abstract][Full Text] [Related]
16. Risk of cancer in cases of suspected lynch syndrome without germline mutation. Rodríguez-Soler M; Pérez-Carbonell L; Guarinos C; Zapater P; Castillejo A; Barberá VM; Juárez M; Bessa X; Xicola RM; Clofent J; Bujanda L; Balaguer F; Reñé JM; de-Castro L; Marín-Gabriel JC; Lanas A; Cubiella J; Nicolás-Pérez D; Brea-Fernández A; Castellví-Bel S; Alenda C; Ruiz-Ponte C; Carracedo A; Castells A; Andreu M; Llor X; Soto JL; Payá A; Jover R Gastroenterology; 2013 May; 144(5):926-932.e1; quiz e13-4. PubMed ID: 23354017 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinicopathologic/molecular characteristics of mismatch repair-deficient colorectal cancer in the under-50-year-old Japanese population. Suzuki O; Eguchi H; Chika N; Sakimoto T; Ishibashi K; Kumamoto K; Tamaru JI; Tachikawa T; Akagi K; Arai T; Okazaki Y; Ishida H Surg Today; 2017 Sep; 47(9):1135-1146. PubMed ID: 28258479 [TBL] [Abstract][Full Text] [Related]
18. Screening for Lynch Syndrome in Young Colorectal Cancer Patients from Saudi Arabia Using Microsatellite Instability as the Initial Test. Alqahtani M; Grieu F; Carrello A; Amanuel B; Mashour M; Alattas R; Alsaleh K; Alsheikh A; Alqahtani S; Iacopetta B Asian Pac J Cancer Prev; 2016; 17(4):1917-23. PubMed ID: 27221876 [TBL] [Abstract][Full Text] [Related]
19. Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel. Abu Freha N; Leibovici Weissman Y; Fich A; Barnes Kedar I; Halpern M; Sztarkier I; Behar DM; Arbib Sneh O; Vilkin A; Baris HN; Gingold R; Lejbkowicz F; Niv Y; Goldberg Y; Levi Z Fam Cancer; 2018 Jan; 17(1):79-86. PubMed ID: 28608265 [TBL] [Abstract][Full Text] [Related]
20. Mismatch repair deficiency in Lynch syndrome-associated colorectal adenomas is more prevalent in older patients. Tanaka M; Nakajima T; Sugano K; Yoshida T; Taniguchi H; Kanemitsu Y; Nagino M; Sekine S Histopathology; 2016 Aug; 69(2):322-8. PubMed ID: 26826556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]